Intel's ambitious foundry business accounts for 33% of revenue, supported by a $7.86 billion grant. Occidental Petroleum focuses on debt reduction, BioNTech shows potential beyond COVID-19 vaccine, McCormick offers growth and dividends, while Coca-Cola faces volume decline.